Adaptation and validation of a quantitative vanA/vanB DNA screening assay on a high-throughput PCR system

Sci Rep. 2024 Feb 12;14(1):3523. doi: 10.1038/s41598-024-54037-5.

Abstract

Vancomycin resistant enterococci (VRE) are a leading cause of ICU-acquired bloodstream infections in Europe. The bacterial load in enteral colonization may be associated with a higher probability of transmission. Here, we aimed to establish a quantitative vanA/vanB DNA real-time PCR assay on a high-throughput system. Limits of detection (LOD), linear range and precision were determined using serial bacterial dilutions. LOD was 46.9 digital copies (dcp)/ml for vanA and 60.8 dcp/ml for vanB. The assay showed excellent linearity between 4.7 × 101 and 3.5 × 105 dcp/ml (vanA) and 6.7 × 102 and 6.7 × 105 dcp/ml (vanB). Sensitivity was 100% for vanA and vanB, with high positive predictive value (PPV) for vanA (100%), but lower PPV for vanB (34.6%) likely due to the presence of vanB DNA positive anerobic bacteria in rectal swabs. Using the assay on enriched VRE broth vanB PPV increased to 87.2%. Quantification revealed median 2.0 × 104 dcp/ml in PCR positive but VRE culture negative samples and median 9.1 × 104 dcp/ml in VRE culture positive patients (maximum: 107 dcp/ml). The automated vanA/B_UTC assay can be used for vanA/vanB detection and quantification in different diagnostic settings and may support future clinical studies assessing the impact of bacterial load on risk of infection and transmission.

Keywords: Molecular diagnostics; Real time polymerase chain reaction; VRE; Vancomycin-resistant enterococci; cobas6800.

MeSH terms

  • Anti-Bacterial Agents
  • Bacterial Proteins / genetics
  • DNA
  • DNA, Bacterial / analysis
  • DNA, Bacterial / genetics
  • Gram-Positive Bacterial Infections* / microbiology
  • Humans
  • Predictive Value of Tests
  • Real-Time Polymerase Chain Reaction
  • Vancomycin-Resistant Enterococci* / genetics

Substances

  • DNA
  • DNA, Bacterial
  • Bacterial Proteins
  • Anti-Bacterial Agents